BACKGROUND: The hereditary paraganglioma syndromes (PGLs) are autosomal dominant conditions with an increased risk for tumors of the sympathetic and parasympathetic neuroendocrine systems. The recognition of patients with hereditary PGL and identification of the responsible gene are important for the management of index patients and family members. METHODS: We present the clinical, radiological, biochemical, and family history findings of a 15-year-old boy patient with a glomus vagale versus glomus jugulare tumor. RESULTS: Evaluation of the family history and the patient's history led to the identification of a familial succinate dehydrogenase subunit D (SDHD) gene mutation (F933>X67), consistent with a diagnosis of hereditary PGL1. Although this family had all head and neck tumors, this SDHD mutation has previously been described in a family with primarily functional pheochromocytomas. CONCLUSIONS: This case report highlights the variable expressivity of a single mutation in SDHD, (F933>X67). Careful and comprehensive screening is warranted for individuals at risk.
BACKGROUND: The hereditary paraganglioma syndromes (PGLs) are autosomal dominant conditions with an increased risk for tumors of the sympathetic and parasympathetic neuroendocrine systems. The recognition of patients with hereditary PGL and identification of the responsible gene are important for the management of index patients and family members. METHODS: We present the clinical, radiological, biochemical, and family history findings of a 15-year-old boypatient with a glomus vagale versus glomus jugulare tumor. RESULTS: Evaluation of the family history and the patient's history led to the identification of a familial succinate dehydrogenase subunit D (SDHD) gene mutation (F933>X67), consistent with a diagnosis of hereditary PGL1. Although this family had all head and neck tumors, this SDHD mutation has previously been described in a family with primarily functional pheochromocytomas. CONCLUSIONS: This case report highlights the variable expressivity of a single mutation in SDHD, (F933>X67). Careful and comprehensive screening is warranted for individuals at risk.
Authors: C Bauters; M-C Vantyghem; E Leteurtre; M-F Odou; C Mouton; N Porchet; J-L Wemeau; C Proye; P Pigny Journal: J Med Genet Date: 2003-06 Impact factor: 6.318
Authors: B Havekes; E P M Corssmit; J C Jansen; A G L van der Mey; A H J T Vriends; J A Romijn Journal: J Clin Endocrinol Metab Date: 2007-01-16 Impact factor: 5.958
Authors: Diana E Benn; Anne-Paule Gimenez-Roqueplo; Jennifer R Reilly; Jérôme Bertherat; John Burgess; Karen Byth; Michael Croxson; Patricia L M Dahia; Marianne Elston; Oliver Gimm; David Henley; Philippe Herman; Victoria Murday; Patricia Niccoli-Sire; Janice L Pasieka; Vincent Rohmer; Kathy Tucker; Xavier Jeunemaitre; Deborah J Marsh; Pierre-François Plouin; Bruce G Robinson Journal: J Clin Endocrinol Metab Date: 2005-11-29 Impact factor: 5.958
Authors: L Simi; R Sestini; P Ferruzzi; M S Gaglianò; F Gensini; M Mascalchi; L Guerrini; C Pratesi; P Pinzani; G Nesi; T Ercolino; M Genuardi; M Mannelli Journal: J Med Genet Date: 2005-08 Impact factor: 6.318
Authors: Hartmut P H Neumann; Christian Pawlu; Mariola Peczkowska; Birke Bausch; Sarah R McWhinney; Mihaela Muresan; Mary Buchta; Gerlind Franke; Joachim Klisch; Thorsten A Bley; Stefan Hoegerle; Carsten C Boedeker; Giuseppe Opocher; Jörg Schipper; Andrzej Januszewicz; Charis Eng Journal: JAMA Date: 2004-08-25 Impact factor: 56.272
Authors: H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste Journal: N Engl J Med Date: 1993-11-18 Impact factor: 91.245
Authors: Henri J L M Timmers; Karel Pacak; Jérôme Bertherat; Jacques W M Lenders; Michèle Duet; Graeme Eisenhofer; Constantine A Stratakis; Patricia Niccoli-Sire; Ba Huy Patrice Tran; Nelly Burnichon; Anne-Paule Gimenez-Roqueplo Journal: Clin Endocrinol (Oxf) Date: 2007-10-31 Impact factor: 3.478
Authors: Mei Yin Wong; Katrina A Andrews; Benjamin G Challis; Soo-Mi Park; Carlo L Acerini; Eamonn R Maher; Ruth T Casey Journal: Clin Endocrinol (Oxf) Date: 2019-01-29 Impact factor: 3.478